Higher levels of hair EtG in patients with decreased kidney function.

Similar documents
Ethyl glucuronide in hair: is it a reliable marker of chronic high levels of alcohol consumption?

ETHYL GLUCURONIDE DETERMINATION IN HAIR AS AN INDICATOR OF CHRONIC ALCOHOL ABUSE: A FULLY VALIDATED METHOD BY GC-EI-MS/MS

Hair ethylglucuronide and blood phosphatidylethanol detection of 4 DUI driver risk factors 1

Occupational exposure to alcohol-based hand sanitizers: the diriment role of alcohol biomarkers in hair

Jennifer P. Pascali, PhD. dtolabs, Resana (TV)

Markers of Alcohol Abuse in Alcoholic Liver Disease: sensitivity and specificity. Alessandro Federico University of Campania L.

Alcohol Biomarkers. BMF 77 - Alcohol Biomarkers

Supplementary Table 1. Criteria for selection of normal control individuals among healthy volunteers

THCCOOH and ETG in hair: analytical challenges and interpretation of results in Forensic Toxicology. Luca Morini

EtG/EtS in Urine from Sexual Assault Victims Determined by UPLC MS-MS

Supplementary Appendix

1D Proton NMR Spectroscopic Determination of Ethanol and Ethyl Glucuronide in Human Urine

Levels of Ethyl Glucuronide and Ethyl Sulfate in Oral Fluid, Blood, and Urine After Use of Mouthwash and Ingestion of Nonalcoholic Wine

Detection of the Direct Alcohol Biomarker Ethyl Glucuronide (EtG) in Hair An Annotated Bibliography

ASSESSMENT AND DETECTION Detection Times for Urinary Ethyl Glucuronide and Ethyl Sulfate in Heavy Drinkers during Alcohol Detoxification

DIABETES AND LABORATORY TESTS. Author: Josephine Davis

Monitoring Road Safety with Alcohol Biomarkers: Types, Measurement, Interpretation, and Recommendations 1

NIH Public Access Author Manuscript Traffic Inj Prev. Author manuscript; available in PMC 2012 April 1.

2/12/2019. Direct biomarkers of alcohol consumption in professionals health programs. Objectives. IPN/PRN Annual Conference and Evaluator Training

Schöttker et al. BMC Medicine (2016) 14:26 DOI /s

DRUG & ALCOHOL TESTING YOUR QUESTIONS ANSWERED

HAIR ALCOHOL TESTING EtG

Review Article. Ethyl glucuronide. Natalie E Walsham 1 and Roy A Sherwood 2

METHOD-DEPENDENT CHARACTERISTICS OF CARBOHYDRATE-DEFICIENT TRANSFERRIN MEASUREMENTS IN THE FOLLOW-UP OF ALCOHOLICS

Evaluation and clinical application of ethyl glucuronide and ethyl sulfate as biomarkers for recent alcohol consumption

Evaluation Report of the Pneumatic Tube Transport System (PEVCO) connecting Dialysis Hospital to. Mubarak Hospital. Dr.

Ethyl Sulfate: A Metabolite of Ethanol in Humans and a Potential Biomarker of Acute Alcohol Intake

QUICK REFERENCE FOR HEALTHCARE PROVIDERS

Case Studies: Renal and Urologic Impairments Workshop

Assessment of Alcohol Exposure: Testing for Ethylglucuronide (Etg), Ethylsulfate (Ets)

Ethyl Glucuronide, Ethyl Sulfate, and Ethanol in Urine after Intensive Exposure to High Ethanol Content Mouthwash

Is Knowing Half the Battle? Behavioral Responses to Risk Information from the National Health Screening Program in Korea

DIAGNOSING X-LINKED HYPOPHOSPHATEMIA (XLH) BIOCHEMICAL TESTING CONSIDERATIONS

MEASUREMENT OF CARBOHYDRATE-DEFICIENT TRANSFERRED (CDT) IN A GENERAL MEDICAL CLINIC: IS THIS TEST USEFUL IN ASSESSING ALCOHOL CONSUMPTION?

Creatinine (serum, plasma)

Chemistry Reference Ranges and Critical Values

Chemistry Reference Ranges and Critical Values

Ethyl glucuronide, a new biochemical marker for acute alcohol intake

Biomarkers, alcohol and health: recognizing the switch from moderation to abuse

Richmond London Borough Council v B, W, B and CB [2010] EWHC 2903 (Fam)

Janis Baines Section Manager, Food Data Analysis, Food Standards Australia New Zealand. Paul Atyeo Assistant Director, ABS Health Section

NIH Public Access Author Manuscript Alcohol Clin Exp Res. Author manuscript; available in PMC 2011 March 1.

SITA 100 mg (n = 378)

Biological markers for abuse and addiction

Sara Castiglioni Mario Negri Institute Department of Environmental Health Sciences Unity of Environmental Biomarkers

Fast and simultaneous analysis of ethanol metabolites and barbiturates using the QTRAP 4500 LC-MS/MS system

Rapid Hydrolysis of Benzodiazepines in Urine. Alicia Zook 1 and Crystal Xander B.S. 2. Cedar Crest College, Allentown, PA 1

Estimation of Serum Creatinine, Urine Creatinine and Creatinine Clearance. BCH472 [Practical] 1

Renal Impairment From Dettli to Guideline: What can we learn?

BIOCHEMICAL REPORT. Parameters Unit Finding Normal Value. Lipase U/L Amylase U/L

A New Approach for Evaluating Renal Function and Predicting Risk. William McClellan, MD, MPH Emory University Atlanta

Relapse of alcohol consumption occurs in

Supplementary Appendix

Supriya Sharma et al., Asian Journal of Pharmaceutical Technology & Innovation, 03 (14); 2015; Research Article

SUISSE ADPKD Cohort Treatment and Outcomes with Tolvaptan, first in class Vasopressin V2 Antagonist. Hirslanden, 22 March 2018 Stefan Russmann

To assess safety profiles: significant laboratory changes and adverse events (AEs).

Fal Fal P h y s i o l o g y 6 1 1, S a n F r a n c i s c o S t a t e U n i v e r s i t y

Science of Drinking: Alcohol Use, Abuse and Alcohol Biomarkers Session # 2000

Supplementary Online Content

ALLHAT RENAL DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED INTO 4 GROUPS BY BASELINE GLOMERULAR FILTRATION RATE (GFR)

Glomerular Filtration Rate. Hui Li, PhD, FCACB, DABCC

The Defined HHS/DOT Substituted Urine Criteria Validated Through a Controlled Hydration Study

Biochemical Investigations in Liver Disease. Dr Roshitha de Silva Department of Pathology Faculty of Medicine University of Kelaniya

EXAM COVER SHEET. Course Code: CLS 432. Course Description: Clinical Biochemistry. Final Exam. Duration: 2 hour. 1st semester 1432/1433.

Introduction. Ahmed I. Al-Asmari 1,2, *, Robert A. Anderson 1, and Patrik Appelblad 3 1. Abstract

CONCENTRATION OF FATTY ACID ETHYL ESTERS IN HAIR OF ALCOHOLICS: COMPARISON TO OTHER BIOLOGICAL STATE MARKERS AND SELF REPORTED-ETHANOL INTAKE

Seung Hyeok Han, MD, PhD Department of Internal Medicine Yonsei University College of Medicine

Screening of Antihistamine Agents (Diphenhydramine) with Blood and Urine Samples by REMEDi-HS System

INTERNATIONAL JOURNAL OF ANATOMY PHYSIOLOGY AND BIOCHEMISTRY

A Review of SAMHSA s Revised Alcohol Biomarkers (EtG/EtS) Advisory - Spring By: Paul L. Cary Toxicology Laboratory University of Missouri

High urinary excretion of kidney injury molecule-1 predicts adverse outcomes in acute kidney injury: a case control study

Εκηίμηζη ηης μεθρικής λειηοσργίας Ε. Μωραλίδης

Orkambi. Orkambi (lumacaftor/ivacaftor) Description

Applicable To Employees of Gundersen Boscobel Area Hospital Laboratory and Gundersen Palmer Lutheran Hospital and Clinics Laboratory.

DETERMINATION OF CANNABINOIDS, THC AND THC-COOH, IN ORAL FLUID USING AN AGILENT 6490 TRIPLE QUADRUPOLE LC/MS

Clinical Impairment of Benzodiazepines Relation between Benzodiazepine Concentrations and Impairment in Apprehended Drivers.

Screening for chronic kidney disease racial implications. Not everybody that pees has healthy kidneys!

QUANTIFYING OPIOIDS USING LIQUID CHROMATOGRAPHY AND GAS CHROMATOGRAPHY TANDEM MASS SPECTROMETRY

Ct=28.4 WAT 92.6% Hepatic CE (mg/g) P=3.6x10-08 Plasma Cholesterol (mg/dl)

Chronic Kidney Disease: Optimal and Coordinated Management

9/22/2015. Timothy W. Lineberry, MD Chief Medical Officer Greater Green Bay Aurora Health Care

ASSESSMENT OF A POINT-OF-CARE DEVICE FOR MEASURING CREATININE IN A COMMUNITY SCREENING PROGRAM FOR CHRONIC KIDNEY DISEASE

RENAL BIOMARKERS: TECHNOLOGIES AND GLOBAL MARKETS

Detection of Cannabinoids in Oral Fluid with the Agilent 7010 GC-MS/MS System

AGE-RELATED CHANGES ON SERUM GGT ACTIVITY AND THE ASSESSMENT OF ETHANOL INTAKE

Relationship Between Blood Alcohol Concentration and Hepatic Enzymes in an Emergency Department

Prof. Armando Torres Nephrology Section Hospital Universitario de Canarias University of La Laguna Tenerife, Canary Islands, Spain.

The future s bright, the future s orange. the challenges of liver disease now and in the next 50 years

PAGE Meeting 2003 Verona, Italy

BCH472 [Practical] 1

A study of effect of alcohol on liver function tests (LFT) in Garhwal hills, India

AKI: definitions, detection & pitfalls. Jon Murray

Point of Care testing and Forensic Medicine

Laboratory Issues David Winsemius, MD, MPH Heritage Laboratories/HooperHolmes

Possibility of Use a Saliva for Determination Ethanol and Opiates

Excretion of Drugs. Prof. Hanan Hagar Pharmacology Unit Medical College

Welcome! Supreme Court of Ohio Specialized Dockets Conference. October 23-24, 2017

Investigator Responsibilities in Protecting Participants in the Conduct of Bioequivalence Studies Cecilia C. Maramba, MD, MScID

PRESCRIBING IN LIVER AND RENAL DISEASE

How and why to measure renal function in patients with liver disease?

Transcription:

MD Jan Toralf Fosen 1, PhD Gudrun Høiseth 1, Ph.D Luca Morini 2, Prof. Jørg Mørland 1. 1 Norwegian Institute of Public Health, Division of forensic medicine and drug abuse research, Oslo, Norway. 2 Department of Legal Medicine and Public Health, Forensic and Pharmaco-Toxicological Science, University of Pavia, Italy. Abstract Background Hair levels of ethyl glucuronide (EtG) are often used in cases where driving qualifications are evaluated, as hair EtG levels are able to differentiate alcohol abstention from social or heavy drinking. Patients with decreased kidney function have delayed excretion of EtG, and increased incorporation into hair could be suspected. Aim The aim of this study was to compare hair EtG levels in patients with decreased kidney function to those seen in healthy volunteers. Methods 19 renal disease patients were included. The levels of EtG in hair were adjusted to estimated daily intake of ethanol (EDI) and compared to 21 previously published healthy individuals. The preliminary results was published earlier this year, but in this publication for the ICADTS-conference 2013, we will in addition present data from a larger material from which data collection is currently taking place. Results The levels of hair EtG in the 19 patients ranged between < limit of detection (LOD) and 134 pg/mg, and the EDI ranged between 0.1 and 28 g. The levels of EtG in hair were significantly higher in the patients with decreased kidney function compared to healthy volunteers (p=0.004). Discussion and conclusions These preliminary results indicate that hair levels of EtG in a population of patients with decreased kidney function should be interpreted with caution. This should be remembered if this analysis is used to asses suitability to hold a driving license. Introduction Long-term alcohol use can be confirmed by EtG in hair. A cut-off value of 30 pg/mg in the proximal 3 cm hair segment has been suggested to detect a high daily intake of alcohol (above 60 g/day) (Potgieter, 2000) during the last three months (Alt, Janda, Seidl, & Wurst, 2000; Morini, Politi, & Polettini, 2009). So far, all published articles indicate that EtG in hair shows the best diagnostic sensitivity and specificity for detection of chronic heavy alcohol consumption compared to other traditional ethanol biomarkers. Prolonged urinary detection times for EtG in patients with decreased kidney function has previously been published (Hoiseth, Nordal, Pettersen, & Morland, 2012). Renal excretion is the major elimination route for EtG. This implies that higher blood concentrations of EtG 1

could be seen in this patient population compared to healthy volunteers, after an identical intake of alcohol. Incorporation of EtG into hair roots may increase due to the increased blood levels of EtG. The aim of this study was therefore to investigate if hair levels of EtG in patients with decreased kidney function differed from those seen in healthy volunteers. Materials and methods The preliminary results of the first 12 patients were published earlier this year (Hoiseth, Morini, Ganss, Nordal, & Morland, 2013). The data collection is currently taking place and we will in this publication present additionally 7 patients, which will give a total of 19 patients with decreased kidney function. Study protocol Non-dialyzed renal disease patients were recruited from the renal failure clinic at Akershus University Hospital, Lørenskog, Norway. Inclusion criteria were serum creatinine value >90 μmol/l in women and >100 μmol/l in men, estimated glomerulus filtration rate (GFR) <60 ml/min/1.73 m 2 (automatically calculated from creatinine using the MDRD formula including age and sex) (Rule, 2007) and a diagnosis of decreased kidney function in the patient s journal. Only patients having a moderate use of alcohol were included in our study which was approved by the National Committee for Research Ethics in Norway, the Norwegian directorate of health and the local ethics committee at Akershus University Hospital. All patients signed informed consent before attending the study. An estimated daily intake of ethanol (EDI) (calculated on the basis of the time-line followback test) for the last three months was obtained by interviewing the patients carefully about type of beverage and amount consumed on a typical day. Information was also received from the patients medical record. This included diagnoses, serum creatinine value and the estimated GFR, as objective measurements of the individual renal function. Values of aspartate aminotransferase (AST), alanine aminotransferase (ALT) and gamma-glutamyl transferase (GGT), were also collected, as objective indicatorsof possible alcohol overconsumption. Hair was collected from each patient by cutting a hair specimen as close as possible to the skin. The 3 cm proximal hair segment, roughly representing the last three months, was submitted for EtG analysis. The results from these renal disease patients was compared to 21 previously published healthy volunteers (Politi, Morini, Leone, & Polettini, 2006). Analytical methods EtG in hair was determined using a previously published method (Morini, Politi, Groppi, Stramesi, & Polettini, 2006). The samples were analysed in LC-MS/MS system. A calibration curve ranging from 3 to 200 pg/mg was used for quantification purposes. The limit of detection (LOD) was 2 pg/mg and the lower limit of quantification was 3 pg/mg. Statistics Differences between hair levels of EtG in patients and healthy volunteers were studied using a multiple linear regression analysis with the EDI as a covariate. The standardized β-values with p-values for a difference between groups (adjusted for doses) are given. A p-value below 0.05 was considered significant. Correlation between hair levels of EtG and GFR or serum creatinine was assessed using Spearman s non-parametric rank correlation test. 2

Results and discussion 19 patients (15 men and 4 women) were included in the present study. The median age was 60 years (range 39-84) and median body mass index was 26.4 kg/m 2 (range 18.9-31.1). All three inclusion criteria for decreased kidney function were present in all patients. The median serum creatinine value was 257 μmol/l (range 130-670). Median estimated GFR was 22.0 ml/min/1.73 m 2 (range 8.0-54.0) and all subjects had a diagnosis of decreased renal function in their medical record. All subjects had ALT, AST and GGT within the normal range ( 50 U/L for ALT and AST, 60 U/L for GGT) (Klauke et al. 1993; Rustad et al. 2004; Szasz 1974). The levels of hair EtG in the 19 patients ranged between < LOD and 134 pg/mg, and EDI ranged between 0.1 and 28 g. This is shown in table 1. In the previously published 21 (12 men and 9 women, median age 32 (range 25-54)) healthy volunteers used for comparison, the hair EtG ranged between < LOD and 35.4 pg/mg and EDI ranged between 2 and 64 g (Politi et al. 2006). The levels of hair EtG (corrected for EDI) in the present study (n=19) were significantly higher than for previously published healthy volunteers (n=21) (β=0.540, p=0.004). This is shown in Fig. 1. In the patients with decreased kidney function (n=19), there was a significant correlation between the level of EtG in hair (corrected for EDI) and the GFR (Spearman s ρ= - 0.545, p=0.016). The correlation between hair EtG (corrected for EDI) and serum creatinine was also statistically significant (Spearman s ρ=0.530, p=0.019). Patient number Hair EtG (pg/mg) EDI (g/day) GFR (ml/min/1.73 Serum creatinine 1 < LOD 0.4 m44.3 2 ) 141 2 12.1 0.8 22.0 192 3 < LOD 0.6 32.4 186 4 < LOD 2.4 18.7 286 5 54.5 7 23.6 178 6 69.6 5.6 8.0 670 7 < LOD 1.4 10.5 390 8 < LOD 0.1 30.4 148 9 < LOD 0.4 39.9 151 10 < LOD 1.6 54.0 130 11 11,6 10 28.0 250 12 134 12 10,3 500 13 < LOD 1.2 15.0 348 14 20.7 1.2 11.2 470 15 26.1 20.6 25.9 226 16 13.7 4.8 16.3 337 17 9.6 0.8 12.3 410 18 31.3 28 11.9 440 19 13.3 10.9 22.2 257 Table 1. Individual data of hair ethyl glucuronide (EtG) and estimated daily intake of ethanol (EDI) last 3 months in 19 patients with renal disease. Glomerulus filtration rate (GFR) and serum creatinine are also shown. Limit of detection (LOD) = 2 pg/mg. 3

Figure 1. Levels of ethyl glucuronide (EtG) in hair corrected for estimated daily intake of ethanol (EDI) in patients with decreased kidney function compared to healthy volunteers. The box length is the interquartile range of Hair EtG / EDI. The line across the inside of the box represents the median value. This study suggests that among social drinkers, levels of EtG in hair are higher in patients with decreased kidney function compared to healthy volunteers. The relation between hair EtG level and GFR or serum creatinine also strengthen this assumption. The possibility of false positive diagnosis of heavy drinking among renal disease patients must be taken into consideration when hair EtG is used to assess suitability to hold a driving license. These results are based on a small number of patients and must be considered to be preliminary. Further studies should be undertaken to gain more insight of interpretation of hair EtG levels. References Alt, A., Janda, I., Seidl, S., & Wurst, F. M. (2000). Determination of ethyl glucuronide in hair samples. Alcohol Alcohol, 35(3), 313-314. Hoiseth, G., Morini, L., Ganss, R., Nordal, K., & Morland, J. (2013). Higher levels of hair ethyl glucuronide in patients with decreased kidney function. Alcohol Clin Exp Res, 37 Suppl 1, E14-16. doi: 10.1111/j.1530-0277.2012.01882.x Hoiseth, G., Nordal, K., Pettersen, E., & Morland, J. (2012). Prolonged urinary detection times of EtG and EtS in patients with decreased renal function. Alcohol Clin Exp Res, 36(7), 1148-1151. doi: 10.1111/j.1530-0277.2011.01713.x Morini, L., Politi, L., Groppi, A., Stramesi, C., & Polettini, A. (2006). Determination of ethyl glucuronide in hair samples by liquid chromatography/electrospray tandem mass spectrometry. J Mass Spectrom, 41(1), 34-42. doi: 10.1002/jms.943 4

Morini, L., Politi, L., & Polettini, A. (2009). Ethyl glucuronide in hair. A sensitive and specific marker of chronic heavy drinking. Addiction, 104(6), 915-920. doi: 10.1111/j.1360-0443.2009.02535.x Politi, L., Morini, L., Leone, F., & Polettini, A. (2006). Ethyl glucuronide in hair: Is it a reliable marker of chronic high levels of alcohol consumption? Addiction, 101(10), 1408-1412. doi: 10.1111/j.1360-0443.2006.01537.x Potgieter, A. (2000). Science, practice and patient needs: the work of the Plinius Maior Society. Alcohol Alcohol, 35(1), 16-24. Rule, A. D. (2007). Understanding estimated glomerular filtration rate: implications for identifying chronic kidney disease. Curr Opin Nephrol Hypertens, 16(3), 242-249. doi: 10.1097/MNH.0b013e328057de8b 5